Humana (NYSE:HUM) Price Target Increased to $335.00 by Analysts at SunTrust Banks

Humana (NYSE:HUM) had its price target upped by SunTrust Banks to $335.00 in a report released on Thursday, The Fly reports. The firm currently has a hold rating on the insurance provider’s stock. SunTrust Banks also issued estimates for Humana’s Q4 2019 earnings at $2.22 EPS, FY2019 earnings at $17.78 EPS, Q1 2020 earnings at $4.80 EPS, Q2 2020 earnings at $5.94 EPS, Q3 2020 earnings at $5.04 EPS, Q4 2020 earnings at $2.86 EPS and FY2020 earnings at $18.64 EPS. The analysts noted that the move was a valuation call.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Several other research firms also recently issued reports on HUM. Berenberg Bank restated a buy rating on shares of Humana in a research note on Monday, October 21st. ValuEngine upgraded shares of Humana from a sell rating to a hold rating in a research note on Wednesday, October 2nd. Deutsche Bank began coverage on shares of Humana in a research note on Thursday, September 12th. They set a hold rating and a $300.00 target price for the company. BMO Capital Markets downgraded shares of Humana from an outperform rating to a market perform rating and decreased their target price for the stock from $345.00 to $290.00 in a research note on Monday, September 30th. Finally, JPMorgan Chase & Co. increased their target price on shares of Humana from $288.00 to $322.00 and gave the stock an overweight rating in a research note on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fourteen have given a buy rating to the company. The stock has an average rating of Buy and an average price target of $322.63.

NYSE HUM traded up $2.44 during trading hours on Thursday, hitting $317.58. The company had a trading volume of 1,173,375 shares, compared to its average volume of 1,220,728. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.75 and a current ratio of 1.75. Humana has a 1-year low of $225.65 and a 1-year high of $342.03. The company has a market cap of $39.82 billion, a PE ratio of 21.83, a price-to-earnings-growth ratio of 1.27 and a beta of 0.85. The business has a 50 day moving average of $277.48 and a 200-day moving average of $270.93.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, November 6th. The insurance provider reported $5.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.58 by $0.45. Humana had a net margin of 4.13% and a return on equity of 22.47%. The company had revenue of $16.24 billion during the quarter, compared to the consensus estimate of $16.15 billion. During the same quarter in the prior year, the firm posted $4.58 earnings per share. Humana’s revenue for the quarter was up 14.3% on a year-over-year basis. Sell-side analysts expect that Humana will post 17.75 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a $0.55 dividend. The ex-dividend date is Monday, December 30th. This represents a $2.20 dividend on an annualized basis and a yield of 0.69%. Humana’s payout ratio is currently 15.12%.

In related news, insider Brian P. Leclaire sold 7,239 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $289.70, for a total value of $2,097,138.30. Following the completion of the sale, the insider now owns 12,994 shares in the company, valued at $3,764,361.80. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.54% of the stock is owned by company insiders.

Institutional investors have recently modified their holdings of the business. Endurance Wealth Management Inc. increased its holdings in Humana by 354.5% in the third quarter. Endurance Wealth Management Inc. now owns 100 shares of the insurance provider’s stock valued at $26,000 after buying an additional 78 shares in the last quarter. Whittier Trust Co. purchased a new position in Humana in the second quarter valued at about $27,000. Next Capital Management LLC purchased a new position in Humana in the second quarter valued at about $27,000. Quest Capital Management Inc. ADV purchased a new position in Humana in the third quarter valued at about $30,000. Finally, Advantage Investment Management LLC increased its holdings in Humana by 287.1% in the second quarter. Advantage Investment Management LLC now owns 120 shares of the insurance provider’s stock valued at $32,000 after buying an additional 89 shares in the last quarter. 92.93% of the stock is owned by institutional investors.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Read More: What is Compound Annual Growth Rate (CAGR)?

The Fly

Analyst Recommendations for Humana (NYSE:HUM)

Leave a Reply

Your email address will not be published. Required fields are marked *

*